Tilray Brands (TLRY) Cash from Operations (2017 - 2026)
Tilray Brands (TLRY) reported Cash from Operations of 21942000.0 for Q1 2026, down 280.87% on a YoY basis from 12131272.74 in Q1 2025, and down 157.02% quarter-over-quarter from 8537000.0 in Q4 2025.
Tilray Brands (TLRY) Cash from Operations (2017 - 2026) Analysis & Trends
Tilray Brands has reported Cash from Operations for 10 years, with the latest figure at 21942000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 280.87% year-over-year to 21942000.0; the trailing twelve-month figure through Feb 2026 stood at 44627000.0 (up 12.64% YoY), and the FY2025 full-year result was 94599000.0, down 206.1% from the prior year.
- Cash from Operations for Q1 2026 stood at 21942000.0, down from 8537000.0 in the prior quarter.
- The five-year high for Cash from Operations was 43598000.0 in Q2 2023, with the low at 46390000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 12725411.76 across 5 years, with a median of 15842000.0 in 2023.
- Annual changes were most pronounced in 2022 — Cash from Operations tumbled 348.81% — and 2023, when it jumped 312.42%.
- Tilray Brands' Cash from Operations stood at 29209000.0 in 2022, then plunged by 204.11% to 30409000.0 in 2023, then tumbled by 33.92% to 40724000.0 in 2024, then surged by 79.04% to 8537000.0 in 2025, then slumped by 157.02% to 21942000.0 in 2026.
- The last three Cash from Operations figures came in at 21942000.0 (Q1 2026), 8537000.0 (Q4 2025), and 1341000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -40.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 401.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 463.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 145.80 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 13.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -165.74 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 89.36 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 125.13 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | -21.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -21.94 Mn |
| Feb 28, 2026 | -21.94 Mn |
| Nov 30, 2025 | -8.54 Mn |
| Nov 30, 2025 | -8.54 Mn |
| Aug 31, 2025 | -1.34 Mn |
| Aug 31, 2025 | -1.34 Mn |
| May 31, 2025 | -12.81 Mn |
| May 31, 2025 | -12.81 Mn |
| Feb 28, 2025 | -5.76 Mn |
| Feb 28, 2025 | -5.76 Mn |
| Nov 30, 2024 | -40.72 Mn |
| Nov 30, 2024 | -40.72 Mn |
| Aug 31, 2024 | -35.31 Mn |
| Aug 31, 2024 | -35.31 Mn |
| May 31, 2024 | 30.71 Mn |
| May 31, 2024 | 30.71 Mn |
| Feb 29, 2024 | -15.36 Mn |
| Feb 29, 2024 | -15.36 Mn |
| Nov 30, 2023 | -30.41 Mn |
| Nov 30, 2023 | -30.41 Mn |